Project Grant HT94252510716
Award Date
8/1/25
Completion Date
7/31/27
Dollars Obligated
$318K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Baltimore, MD 21218, USA
Similar Awards
The Department of Defense's Defense Health Agency awarded a $319,240 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to The Johns Hopkins University. The grant, awarded on September 1, 2025, will fund research to characterize microRNAs involved in regulating human oligodendrocyte maturation and myelin formation. This research, to be conducted over 2 years until August 31, 2027, aims to transform healthcare for military service members, veterans, and the...
The U.S. Defense Health Agency awarded a $621,011 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to The Johns Hopkins University. The grant, with a performance period from July 1, 2025 to June 30, 2027, will fund research targeting sensory neurons via anti-CGRP therapies in osteosarcoma. As a leading federal contractor and grantee, The Johns Hopkins University has demonstrated extensive capabilities in advanced biomedical research across diverse medical...
The Johns Hopkins University has been awarded a $1,099,238 Project Grant under the Department of Defense's Military Medical Research and Development program (CFDA 12.420) with a period of performance from September 1, 2024 to August 31, 2026. This grant will support investigator-initiated biomedical research projects across multiple medical disciplines to improve health outcomes for military service members, veterans, and the broader public. The award enables Johns Hopkins to conduct...
The Johns Hopkins University received a $248,356 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to conduct research on "Cardiometabolic Comorbidity and Outcomes in Multiple Sclerosis: A Polygenic Risk Score Approach". The award period runs from September 1, 2023 to August 31, 2025. The project aims to investigate medical solutions for the battlefield through innovative and impactful biomedical research....
The Department of the Army Medical Command awarded a $319,938 project grant under the Military Medical Research and Development (CFDA 12.420) program to The Johns Hopkins University. The grant, with a performance period from September 1, 2024 to August 31, 2026, will fund a large-scale MRI-based study to determine multiple sclerosis-specific atrophy phenotypes. This research aims to transform healthcare for military service members and the broader public by advancing the understanding and...
The U.S. Department of Defense's Defense Health Agency awarded a $1,738,924 Project Grant to The Johns Hopkins University to conduct research on "Proteomics of Atrioventricular Septal Defect in Down Syndrome" from September 1, 2024 through August 31, 2028. This research, funded under the Military Medical Research and Development program (CFDA 12.420), aims to advance scientific understanding and treatment of this condition impacting military members, veterans, and their families. The...
The U.S. Defense Health Agency awarded a $2,382,063 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to The Johns Hopkins University on May 15, 2025. The grant, titled "NERVE TO HEAL: OPTIMIZATION OF TENDON HEALTH USING NERVE-SPECIFIC SMALL MOLECULES", supports advanced biomedical research to transform healthcare for military service members, veterans, and the public. Johns Hopkins has subcontracted a portion of the work to Stanford University...
The Johns Hopkins University will provide research services under a $724,845 Project Grant from the Defense Health Agency's Military Medical Research and Development program. Specifically, Johns Hopkins will conduct applied biomedical studies from June 2023 through May 2026 to regenerate chronically denervated muscle through development of an injectable myoblast scaffold. The Military Medical Research and Development program aims to transform military and public health through innovative...
The federal Project Grant award of $465,568.00 from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports research at The Johns Hopkins University on the role of epitranscriptomic modulators in response to bipolar androgen therapy. The award period runs from September 15, 2025 to September 14, 2027 and aims to transform healthcare for military service members, veterans, and the public through innovative biomedical research. As a leading...
The Department of Defense's Defense Health Agency awarded a $232,878 Project Grant to The Johns Hopkins University to conduct research on "EXPLORING THE ROLE OF EPITRANSCRIPTOMICS IN THE EVOLUTION OF NEUROENDOCRINE PROSTATE CANCER." This grant is funded through the Military Medical Research and Development (CFDA 12.420) program, which supports advanced biomedical research to transform healthcare for military service members, veterans, and the public. The research will be conducted from...